arrow
A

Anna Heidbreder

bg universitatsklinikum bergmannsheil bochum
H指数:36
被引数:4,913

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Brainstem pathology in anti-IgLON5 disease: new insights into early events and tau progression

抗-IgLON5病中的脑干病理:对早期事件和tau蛋白进展的新见解

Brain
IF11.7
2026-04-011
PRE
Postural orthostatic tachycardia syndrome is the most frequent cardiovascular autonomic disorder following COVID-19 infection or vaccination

直立不耐受性心动过速综合征是COVID-19感染或疫苗接种后最常见的自主心血管障碍。

2025-11-220
OAAI
Brain atrophy patterns in anti-IgLON5 disease

抗IgLON5病中的脑萎缩模式

Brain
IF11.7
2025-07-120
OAAI
Interim analysis of a post-authorization safety study of pitolisant in treating narcolepsy: A real-world European study

pitolisant治疗发作性睡病的授权后安全性研究的中期分析: 一项真实的欧洲研究

2025-05-010
PRE
Lack of epistatic interaction of SNCA with APOE in synucleinopathies

帕金森病中SNCA与APOE缺乏表观遗传交互作用

2025-01-010
PRE
Daytime sleepiness and BMI exhibit gender and age differences in patients with central disorders of hypersomnolence
2024-10-212
OAAI
Neuropathological spectrum of anti-IgLON5 disease and stages of brainstem tau pathology: updated neuropathological research criteria of the disease-related tauopathy

anti-IgLON5疾病的神经病理谱和脑干tau病理分期: 疾病相关tau病的最新神经病理研究标准

2024-10-140
OAAI
HLA dependency and possible clinical relevance of intrathecally synthesized anti-IgLON5 IgG4 in anti-IgLON5 disease
2024-05-162
OAAI
HLA-DQB1*05 subtypes and not DRB1*10:01 mediates risk in anti-IgLON5 disease

HLA-DQB1 * 05亚型而非DRB1 * 10:01介导anti-IgLON5疾病的风险

BRAIN
IF11.7
2024-03-019
PRE